High coverage and timeliness of vaccination of children under 6 years of age in Risaralda, Colombia

References

• Carrasquilla G, Porras-Ramírez A, Martinez S, DeAntonio R, Devadiga R, Talarico C, Caceres DC, Castrejon MM, Juliao P. Trends in all-cause pneumonia and otitis media in children aged <2 years following pneumococcal conjugate vaccine introduction in Colombia. Hum Vaccin Immunother. 2021;17(4):1173–7. doi:10.1080/21645515.2020.1805990.
   PubMed Web of Science ®Google Scholar
• Maciosek MV, LaFrance AB, Dehmer SP, McGree DA, Flottemesch TJ, Xu Z, Solberg LI. Updated priorities among effective clinical preventive services. Ann Fam Med. 2017;15(1):14–22. doi:10.1370/afm.2017.
   PubMed Web of Science ®Google Scholar
• Whitney CG, Zhou F, Singleton J, Schuchat A. Centers for disease control and prevention (CDC). Benefits from immunization during the vaccines for children program era - United States, 1994–2013. MMWR Morb Mortal Wkly Rep. 2014;63:352–5.
   PubMed Web of Science ®Google Scholar
• Rashid H, Khandaker G, Booy R. Vaccination and herd immunity: what more do we know? Curr Opin Infect Dis. 2012;25(3):243–9. doi:10.1097/QCO.0b013e328352f727.
   PubMed Web of Science ®Google Scholar
• Kim TH, Johnstone J, Loeb M. Vaccine herd effect. Scand J Infect Dis. 2011;43(9):683–9. doi:10.3109/00365548.2011.582247.
   PubMed Web of Science ®Google Scholar
• Masters NB, Wagner AL, Boulton ML. Vaccination timeliness and delay in low- and middle-income countries: a systematic review of the literature, 2007–2017. Hum Vaccin Immunother. 2019;15(12):2790–805. doi:10.1080/21645515.2019.1616503.
   PubMed Web of Science ®Google Scholar
• Ministerio de Salud de Colombia - Plan de Respuesta del sector salud al fenómeno migratorio. Bogotá (DC), Colombia; 2018 [accessed 2022 Feb 1]. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/COM/plan-respuesta-salud-migrantes.pdf.
   Google Scholar
• Perfil Migratorio de Colombia 2021. International organization for migration. UN Migration. PUB2022/127/R. 2022 [accessed 2023 Jul 31]. https://publications.iom.int/books/perfil-migratorio-de-colombia-2021.
   Google Scholar
• Gobernación de Risaralda. En Risaralda hay más de 33 mil migrantes venezolanos con el Permiso por Protección temporal. Colombia; 2022 [accessed 2023 Jul 31]. https://www.risaralda.gov.co/publicaciones/157302/en-risaralda-hay-mas-de-33-mil-migrantes-venezolanos-con-el-permiso-por-proteccion-temporal/#:~:text=Seg%C3%BAn%20informaci%C3%B3n%20de%20Migraci%C3%B3n%20Colombia,que%20garantizan%20los%20derechos%20de.
   Google Scholar
• Salmon DA, Dudley MZ, Glanz JM, Omer SB. Vaccine hesitancy: causes, consequences, and a call to action. Am J Prev Med. 2015;49(6 Suppl 4):S391–8. doi:10.1016/j.amepre.2015.06.009.
   PubMed Web of Science ®Google Scholar
• Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine. 2014;32(19):2150–9. doi:10.1016/j.vaccine.2014.01.081.
   PubMed Web of Science ®Google Scholar
• Attwell KC, Navin M. Childhood vaccination mandates: scope, sanctions, severity, selectivity, and salience. Milbank Q. 2019;97(4):978–1014. doi:10.1111/1468-0009.12417.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Immunization schedules. [accessed 2023 Apr 18]. https://www.who.int/immunization/policy/schedules/en/.
   Google Scholar
• Newcomer SR, Glanz JM, Daley MF. Beyond vaccination coverage: population-based measurement of early childhood immunization schedule adherence. Acad Pediatr. 2023;23(1):24–34. doi:10.1016/j.acap.2022.08.003.
   PubMed Web of Science ®Google Scholar
• Bailly AC, Gras P, Lienhardt JF, Requillart JC, Vié-le-Sage F, Martinot A, Dubos F. Timeliness of vaccination in infants followed by primary-care pediatricians in France. Hum Vaccin Immunother. 2018;14(4):1018–23. doi:10.1080/21645515.2017.1409318.
   PubMed Web of Science ®Google Scholar
• Narváez J, Osorio MB, Castañeda-Orjuela C, Alvis Zakzuk N, Cediel N, Chocontá-Piraquive LÁ, de La Hoz-Restrepo F. Is Colombia reaching the goals on infant immunization coverage? A quantitative survey from 80 municipalities. Vaccine. 2017;35(11):1501–8. doi:10.1016/j.vaccine.2017.01.073.
   PubMed Web of Science ®Google Scholar
• de la Hoz F, Perez L, de Neira M, Hall AJ. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness. Int J Infect Dis. 2008;12(2):183–9. doi:10.1016/j.ijid.2007.06.010.
   PubMed Web of Science ®Google Scholar
• Morón-Duarte L, Espitia MT. A rapid evaluation of vaccination coverage in Bogotá, 2006. Rev Salud Publica (Bogota). 2009;11(2):237–46. doi:10.1590/S0124-00642009000200008.
   PubMedGoogle Scholar
• Ministerio de la Protección Social. Lineamiento para la evaluación de coberturas, oportunidad y esquema completo de vacunación. Bogotá, Colombia; 2011 [accessed 2022 Feb 1]. https://www.minsalud.gov.co/Lineamientos/Lineamiento%20para%20la%20evaluaci%C3%B3n%20de%20coberturas.pdf.
   Google Scholar
• Rico-Villademoros F, Postigo-Martin P, Garcia-Leiva JM, Ordoñez-Carrasco JL, Calandre EP. Patterns of pharmacologic and non-pharmacologic treatment, treatment satisfaction and perceived tolerability in patients with fibromyalgia: a patients’ survey. Clin Exp Rheumatol. 2020;38:72–8.
   PubMed Web of Science ®Google Scholar
• DANE. Resultados Censo Nacional de Población y Vivienda 2018. Pereira, Risaralda; 2019 [accessed 2022 Feb 1]. https://www.dane.gov.co/files/censo2018/informacion-tecnica/presentaciones-territorio/190731-CNPV-presentacion-Risaralda-Pereira.pdf.
   Google Scholar
• Cotes K, Alvis-Guzmán N, Rico A, Porras A, Cediel N, Chocontá Piraquive LA, De la Hoz F. Evaluación del impacto de la vacuna contra rotavirus en Colombia usando métodos rápidos de evaluación [Impact assessment of the rotavirus vaccine in Colombia using rapid evaluation methods]. Rev Panam Salud Publica. 2013;34:220–6.
   PubMed Web of Science ®Google Scholar
• Arat A, Moore HC, Goldfeld S, Östberg V, Sheppeard V, Gidding HF. Childhood vaccination coverage in Australia: an equity perspective. BMC Public Health. 2021;21(1):1337. doi:10.1186/s12889-021-11345-z.
   PubMed Web of Science ®Google Scholar
• Mutua MK, Mohamed SF, Porth JM, Faye CM. Inequities in on-time childhood vaccination: evidence from Sub-Saharan Africa. Am J Prev Med. 2021;60(1 Suppl 1):S11–S23. doi:10.1016/j.amepre.2020.10.002.
   PubMed Web of Science ®Google Scholar
• Branco FL, Pereira TM, Delfino BM, Braña AM, Oliart-Guzmán H, Mantovani SA, Martins AC, Oliveira CS, Ramalho AA, Codeço CT, et al. Socioeconomic inequalities are still a barrier to full child vaccine coverage in the Brazilian Amazon: a cross-sectional study in Assis Brasil, Acre, Brazil. Int J Equity Health. 2014;13:118. doi:10.1186/s12939-014-0118-y.
   PubMed Web of Science ®Google Scholar
• Luman ET, Barker LE, Shaw KM, McCauley MM, Buehler JW, Pickering LK. Timeliness of childhood vaccinations in the United States: days undervaccinated and number of vaccines delayed. JAMA. 2005;293(10):1204–11. doi:10.1001/jama.293.10.1204.
   PubMed Web of Science ®Google Scholar
• Rincón Villamizar HI, Escobar Ortiz JL. IDH y PIB en Colombia: un análisis de convergencia departamental. 2019 [accessed 2022 Feb 1]. chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://repository.ucatolica.edu.co/bitstream/10983/23858/1/IDH%20y%20PIB%20en%20Colombia%2C%20un%20an%C3%A1lisis%20de%20convergencia%20departamental.pdf.
   Google Scholar
• Bonet-Morón J, Guzmán-Finol K. Un análisis regional de la salud en Colombia. Documentos de Trabajo Sobre Economía Regional y Urbana; No 222. 2015 [accessed 2022 Feb 1]. chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.banrep.gov.co/sites/default/files/publicaciones/archivos/dtser_222.pdf.
   Google Scholar
• Fadnes LT, Nankabirwa V, Sommerfelt H, Tylleskär T, Tumwine JK, Engebretsen IM, PROMISE-EBF Study Group. Is vaccination coverage a good indicator of age-appropriate vaccination? A prospective study from Uganda. Vaccine. 2011;29(19):3564–70. doi:10.1016/j.vaccine.2011.02.093.
   PubMed Web of Science ®Google Scholar
• Gras P, Bailly AC, Lagrée M, Dervaux B, Martinot A, Dubos F. What timing of vaccination is potentially dangerous for children younger than 2 years? Hum Vaccin Immunother. 2016;12(8):2046–52. doi:10.1080/21645515.2016.1157239.
   PubMed Web of Science ®Google Scholar
• Rane MS, Rohani P, Halloran ME. Association of diphtheria-tetanus-acellular pertussis vaccine timeliness and number of doses with age-specific pertussis risk in infants and young children. JAMA Netw Open. 2021;4(8):e2119118. doi:10.1001/jamanetworkopen.2021.19118.
   PubMed Web of Science ®Google Scholar
• Tang XY, Yan XX, Wei X, Qin QL, Lin YD, Geater A, Deng QY, Zhong G, Li Q. Timeliness, completeness, and timeliness-and-completeness of serial routine vaccinations among rural children in Southwest China: a multi-stage stratified cluster sampling survey. Vaccine. 2021;39(24):3236–49. doi:10.1016/j.vaccine.2021.04.048.
   PubMed Web of Science ®Google Scholar
• Mthiyane TN, Cohen C, Norris SA, Walaza S, Tempia S, Cohen AL, Von Gottberg A, Von Mollendorf C. Factors associated with missed and delayed DTP3 vaccination in children aged 12 - 59 months in two communities in South Africa, 2012–2013. S Afr Med J. 2019;109(8):562–9. doi:10.7196/SAMJ.2019.v109i8.13244.
   PubMed Web of Science ®Google Scholar
• Raguindin PF, Morales-Dizon M, Aldaba J, Mangulabnan LP, Reyes RP, Batmunkh N, Ducusin MJ, Lopez AL. Timeliness of childhood vaccinations in the Philippines. J Public Health Policy. 2021;42(1):53–70. doi:10.1057/s41271-020-00255-w.
   PubMed Web of Science ®Google Scholar
• Radhakrishnan L, Stein Z, DeVies J, Smith A, Sheppard M, Hartnett KP, Kite-Powell A, Adjemian J, Rodgers LE. Syndromic surveillance of vaccine-associated adverse events in U.S. emergency departments. Vaccine. 2021;39(31):4250–5. doi:10.1016/j.vaccine.2021.06.030.
   PubMed Web of Science ®Google Scholar
• Colomé-Hidalgo M, Donado Campos J, Gil de Miguel Á. Monitoring inequality changes in full immunization coverage in infants in Latin America and the Caribbean. Rev Panam Salud Publica. 2020;44:e56. doi:10.26633/RPSP.2020.56.
   PubMed Web of Science ®Google Scholar
• Gidengil C, Goetz MB, Newberry S, Maglione M, Hall O, Larkin J, Motala A, Hempel S. Safety of vaccines used for routine immunization in the United States: an updated systematic review and meta-analysis. Vaccine. 2021;39(28):3696–716. doi:10.1016/j.vaccine.2021.03.079.
   PubMed Web of Science ®Google Scholar
• Zhou F, Shefer A, Wenger J, Messonnier M, Wang LY, Lopez A, Moore M, Murphy TV, Cortese M, Rodewald L. Economic evaluation of the routine childhood immunization program in the United States, 2009. Pediatrics. 2014;133(4):577–85. doi:10.1542/peds.2013-0698.
   PubMed Web of Science ®Google Scholar
• Toor J, Echeverria-Londono S, Li X, Abbas K, Carter ED, Clapham HE, Clark A, de Villiers MJ, Eilertson K, Ferrari M, et al. Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world. Elife. 2021;10:e67635. doi:10.7554/eLife.67635.
   PubMed Web of Science ®Google Scholar
• Bramer CA, Kimmins LM, Swanson R, Kuo J, Vranesich P, Jacques-Carroll LA, Shen AK. Decline in child vaccination coverage during the COVID-19 pandemic - Michigan care improvement registry, May 2016–May 2020. MMWR Morb Mortal Wkly Rep. 2020;69(20):630–1. doi:10.15585/mmwr.mm6920e1.
   PubMed Web of Science ®Google Scholar
• Abbas K, Procter SR, van Zandvoort K, Clark A, Funk S, Mengistu T, Hogan D, Dansereau E, Jit M, Flasche S, et al. Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection. Lancet Glob Health. 2020;8(10):e1264–e72. doi:10.1016/S2214-109X(20)30308-9.
   PubMed Web of Science ®Google Scholar
• Chandir S, Siddiqi DA, Mehmood M, Setayesh H, Siddique M, Mirza A, Soundardjee R, Dharma VK, Shah MT, Abdullah S, et al. Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: an analysis of provincial electronic immunization registry data. Vaccine. 2020;38(45):7146–55. doi:10.1016/j.vaccine.2020.08.019.
   PubMed Web of Science ®Google Scholar
• Saitoh A, Okabe N. Changes and remaining challenges for the Japanese immunization program: closing the vaccine gap. Vaccine. 2021;39(22):3018–24. doi:10.1016/j.vaccine.2021.04.023.
   PubMed Web of Science ®Google Scholar
• Escobar-Díaz F, Bibiana Osorio-Merchán M, De la Hoz-Restrepo F. Motivos de no vacunación en menores de cinco años en cuatro ciudades colombianas [Reasons some children under 5 do not get vaccinated in four Colombian citiesMotivos por que não são vacinadas crianças menores de cinco anos em quatro cidades colombianas]. Rev Panam Salud Publica. 2017;41:e123. Spanish. doi:10.26633/RPSP.2017.123.
   PubMedGoogle Scholar
• Kempe A, O’Leary ST, Cortese MM, Crane LA, Cataldi JR, Brtnikova M, Beaty BL, Hurley LP, Gorman C, Tate JE, et al. Why aren’t we achieving high vaccination rates for rotavirus vaccine in the United States? Acad Pediatr. 2022;22(4):542–50. doi:10.1016/j.acap.2021.07.003.
   PubMed Web of Science ®Google Scholar
• Fournet N, Mollema L, Ruijs WL, Harmsen IA, Keck F, Durand JY, Cunha MP, Wamsiedel M, Reis R, French J, et al. Under-vaccinated groups in Europe and their beliefs, attitudes and reasons for non-vaccination; two systematic reviews. BMC Public Health. 2018;18(1):196. doi:10.1186/s12889-018-5103-8.
   PubMed Web of Science ®Google Scholar
• Instituto Nacional de Salud. Informe Quincenal Epidemiológico Nacional (IQEN). INFORME DE EVENTO, Colombia 2019 Bogotá, Colombia. 2019 [accessed 2022 Feb 1]. https://www.ins.gov.co/buscador-eventos/Paginas/IQEN.aspx.
   Google Scholar